ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,620.85
      0.42%
      US Tech 100
      19,312.00
      0.06%
      Dow Jones
      40,890.49
      0.14%
      Brent Oil
      75.695
      0.01%
      Bitcoin
      60,910.57
      3.21%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Legend Biotech Corporation (LEGN) Quote

      Legend Biotech Corporation

      Legend Biotech Corporation (LEGN)

      NASDAQ
      56.46
      -0.60
      (-1.05%)
      Closed August 21 4:00PM
      Delayed by 15 minutes
      56.46
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      56.46
      Bid
      53.10
      Ask
      58.50
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      10.271B
      Previous Close
      56.46
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      181,911,035
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      285.14M
      Net Profit
      -518.25M

      About Legend Biotech Corporation

      Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treat... Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.legendbiotech.com
      Headquarters
      Grand Cayman, Cym
      Founded
      1970
      Legend Biotech Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LEGN. The last closing price for Legend Biotech was $56.46. Over the last year, Legend Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

      Legend Biotech currently has 181,911,035 shares outstanding. The market capitalization of Legend Biotech is $10.27 billion.

      LEGN Latest News

      More News

      FeaturedMawson Finland Provides Update on Exploration Activities at Rajapalot

      19 hours ago

      Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

      SOMERSET, N.J., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the...

      August 20 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 09 2024
      Edgar (US Regulatory)

      Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

      CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $186 millionMHRA and Health Canada approved CARVYKTI® in earlier lines of treatment for adult patients with...

      August 09 2024
      GlobeNewswire Inc.

      US Futures Climb Following Thursday’s Rally, Oil Prices Steady

      U.S. stock futures advanced in pre-market trading on Friday, extending the recovery seen on Thursday after Monday’s selloff. Despite recent gains, the S&P 500, Nasdaq, and Dow are still down...

      August 09 2024
      IH Market News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 08 2024
      Edgar (US Regulatory)

      Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors

      SOMERSET, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Peter Salovey...

      August 08 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      July 26 2024
      Edgar (US Regulatory)

      Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

      SOMERSET, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced preliminary, unaudited financial...

      July 26 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      July 17 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.135
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.42
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.55
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.62
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.135
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.42
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.55
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.62
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.135
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 62.42
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.55
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 9.75
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.62
      (0.00%)
      		0

      LEGN Discussion

      View Posts
      Monksdream Monksdream 5 months ago
      LEGN 10Q due March 11
      👍️0

      Your Recent History

      NASDAQ
      LEGN
      Legend Biotech
      Delayed Upgrade Clock